112 related articles for article (PubMed ID: 8371203)
1. Renal effects of low dose methotrexate in rheumatoid arthritis.
Seideman P; Müller-Suur R; Ekman E
J Rheumatol; 1993 Jul; 20(7):1126-8. PubMed ID: 8371203
[TBL] [Abstract][Full Text] [Related]
2. Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.
Seideman P; Müller-Suur R
Ann Rheum Dis; 1993 Aug; 52(8):613-5. PubMed ID: 8215627
[TBL] [Abstract][Full Text] [Related]
3. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
4. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
5. Chromium-51-EDTA clearance in adults with a single-plasma sample.
Mårtensson J; Groth S; Rehling M; Gref M
J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of renal function after high-dose methotrexate treatment in children.
Grönroos MH; Jahnukainen T; Möttönen M; Perkkiö M; Irjala K; Salmi TT
Pediatr Blood Cancer; 2008 Oct; 51(4):535-9. PubMed ID: 18523995
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
Kremer JM; Petrillo GF; Hamilton RA
J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
[TBL] [Abstract][Full Text] [Related]
9. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group.
J Rheumatol; 1995 Feb; 22(2):218-23. PubMed ID: 7738941
[TBL] [Abstract][Full Text] [Related]
10. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
Kremer JM; Hamilton RA
J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
12. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
13. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
Karie S; Gandjbakhch F; Janus N; Launay-Vacher V; Rozenberg S; Mai Ba CU; Bourgeois P; Deray G
Rheumatology (Oxford); 2008 Mar; 47(3):350-4. PubMed ID: 18238787
[TBL] [Abstract][Full Text] [Related]
14. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
McKendry RJ; Dale P
J Rheumatol; 1993 Nov; 20(11):1850-6. PubMed ID: 8308769
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of renal tubular transport of methotrexate by probenecid.
Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous estimation of glomerular filtration rate and renal plasma flow.
Fresco GF; DiGiorgio F; Curti GL
J Nucl Med; 1995 Sep; 36(9):1701-6. PubMed ID: 7658234
[TBL] [Abstract][Full Text] [Related]
18. Low dose methotrexate in rheumatoid arthritis.
Steinsson K; Weinstein A; Korn J; Abeles M
J Rheumatol; 1982; 9(6):860-6. PubMed ID: 7161777
[TBL] [Abstract][Full Text] [Related]
19. [Validity of iohexol clearance in patients with chronic renal failure and normal renal function in comparison to (99m)Tc-DTPA-clearance].
Wiendieck E; Hartung R; Fünfstück R; Keil E; Gottschild D; Stein G
Dtsch Med Wochenschr; 2003 Jan; 128(3):76-80. PubMed ID: 12529836
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
